Loading…

The diagnosis and treatment of castrate-sensitive oligometastatic prostate cancer: A review

Background Oligometastatic prostate cancer (OMPCa) is emerging as a transitional disease state between localized and polymetastatic disease. This review will assess the current knowledge of castrate-sensitive OMPCa. Methods A review of the current literature was performed to summarize the definition...

Full description

Saved in:
Bibliographic Details
Published in:Prostate cancer and prostatic diseases 2023-12, Vol.26 (4), p.702-711
Main Authors: Vanden Berg, Rand N. Wilcox, Zilli, Thomas, Achard, VĂ©rane, Dorff, Tanya, Abern, Michael
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Oligometastatic prostate cancer (OMPCa) is emerging as a transitional disease state between localized and polymetastatic disease. This review will assess the current knowledge of castrate-sensitive OMPCa. Methods A review of the current literature was performed to summarize the definition and classification of OMPCa, assess the diagnostic methods and imaging modalities utilized, and to review the treatment options and outcomes. We further identify gaps in knowledge and areas for future research. Results Currently there is no unified definition of OMPCa. National guidelines mostly recommend systemic therapies without distinguishing oligometastatic and polymetastatic disease. Next generation imaging is more sensitive than conventional imaging and has led to early detection of metastases at initial diagnosis or recurrence. While mostly retrospective in nature, recent studies suggest that treatment (surgical or radiation) of the primary tumor and/or metastatic sites might delay initiation of androgen deprivation therapy while increasing survival in selected patients. Conclusions Prospective data are required to better assess the incremental improvement in survival and quality of life achieved with various treatment strategies in patients with OMPCa.
ISSN:1365-7852
1476-5608
DOI:10.1038/s41391-023-00688-w